Latest Rofecoxib Stories

2008-12-13 00:15:13

Pharmaceutical giant Wyeth arranged ghost-written articles in medical journals on its hormone replacement therapy, U.S. Sen. Charles Grassley said Friday. Grassley, R-Iowa, asked the company, based in New Jersey, and DesignWrite, a medical writing company, to provide details including payment for the articles on Prempro and the involvement of doctors who signed them, The New York Times reported. Members of Grassley's staff released documents showing that Wyeth had been recruiting ghost...

2008-12-03 14:45:55

Researchers argued on Tuesday that quicker drug approvals and sophisticated marketing campaigns may be putting more patients at risk of dangerous side-effects, but the same techniques might be put to use to protect them. Dr. David Kao of the University of Colorado Health Sciences Center said the new U.S. Food and Drug Administration procedures have clearly sped up some drug approvals. For instance, over 20 million patients had tried Merck's anti-inflammatory drug Vioxx, or rofecoxib, before...

2008-10-21 18:00:25

Dynavax Technologies Corporation (NASDAQ:DVAX) and Merck & Co., Inc. have received communication from the U.S. Food and Drug Administration (FDA) regarding the two companies' response to the agency's request for safety information relating to the clinical hold on the two Investigational New Drug (IND) Applications for HEPLISAV(TM), an investigational hepatitis B virus (HBV) vaccine. The FDA has advised the companies that the balance of risk versus potential benefit no longer favors...

2008-10-14 14:49:06

Researchers said on Monday that a long-term analysis of people who took the arthritis drug Vioxx confirms it doubles the risk of strokes and heart attacks, but this risk goes away a year after people stop taking it. They also said other drugs in the same class of painkillers known as Cox-2 inhibitors may cause similar harm. "The good news is the data suggests that the risk doesn't persist forever. The risk goes back toward normal after a year of follow up," said Dr. Robert Bresalier of the...

2008-10-10 03:00:09

By Johnson, Linda A TRENTON, N.J. - Just about every segment of the medical community is piling on the pharmaceutical industry these days, accusing drugmakers of deceiving the public, manipulating doctors and putting profits before patients. Recent articles and editorials in major medical journals blast the industry. Medical schools, teaching hospitals and physician groups are changing rules to limit the influence of pharmaceutical sales reps. And three top editors of the prestigious New...

2008-10-04 15:00:05

For the sake of greater transparency, pharmaceutical giant Eli Lilly has just announced that it will begin making public certain payments to doctors. The practice will begin next year and will apply to fees of $500 or more paid for advising or speaking. Later on, Lilly pledges to disclose travel, entertainment and gifts as well. It would be nice if other drug companies followed suit, but don't count on it. Over several years, the industry and physicians have forged strikingly cozy...

2008-10-03 12:00:27

Merck & Co has announced that it will not seek regulatory approval for taranabant, an investigational medicine, to treat obesity and is discontinuing its Phase III clinical development program for taranabant for obesity. John Amatruda, senior vice president and research head of diabetes and obesity at Merck Research Laboratories, said: "Available Phase III data showed that both efficacy and adverse events were dose related, with greater efficacy and more adverse events in the higher...

2008-09-11 03:00:08

By Brezis, Mayer Belmaker, R H Mayer Brezis, MD, MPH Center for Clinical Quality & Safety, Hadassah Medical Center & School of Public Health, The Hebrew University of Jerusalem, Israel Abstract: A landmark paper on Game Theory showed that individual maximization of profit necessarily endangers the public good, and since the problem has no technical solution, "it requires a fundamental extension in morality" (1). We propose here that public health, as a public good, now emerges as...

2008-09-08 12:00:08

By Lisa Smyth Cases of heart disease and strokes could be cut by simply taking an aspirin a day, medical experts have said. Lisa Smyth examines the latest claims being made about the so-called wonder drug Aspirin has hit the headlines again - this time for its apparent revolutionary powers to ward off some of the UK's biggest killers before they happen. Medical experts have prescribed a daily dose of aspirin for millions of people to beat heart disease and strokes. Researchers...

2008-08-20 10:31:44

The primary purpose of a 1999 clinical study that Merck & Co Inc said was done to test side effects of Vioxx, was actually to support a marketing campaign before the now-withdrawn painkiller's launch, according to U.S. researchers. The real aim of the study, called Advantage, was to promote prescription of the new medicine when it became available -- a so-called "seeding" project -- the researchers said on Tuesday. The research team based its conclusions on an extensive trawl of Merck...

Word of the Day
  • Remarkable; prodigious.
  • Audacious; gutsy.
  • Completely; extremely.
  • Audaciously; boldly.
  • Impressively great in size; enormous; extraordinary.
This word is probably from the dialectal 'boldacious,' a blend of 'bold' and 'audacious.'